Skip to content
value.today

Biogen Inc. vs Pfizer Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Pfizer Inc. is the larger company by market value: $170.7 B against $37.5 B for Biogen Inc., 4.5 times as much (market caps of Oct 23, 2026 for Biogen Inc. and Oct 30, 2026 for Pfizer Inc.).
  • Pfizer Inc. had more revenue: $62.6 B against $9.9 B for Biogen Inc., both in the year to December 2025.
  • Pfizer Inc. earned more: net income of $7.8 B against $1.3 B for Biogen Inc.
  • Biogen Inc. keeps more of each dollar of sales: a net margin of 13.1% against 12.4% for Pfizer Inc.
  • Pfizer Inc. employs more people: 75,000 against 7,500 at Biogen Inc. Each employee brings in about $1,318,747 of revenue at Biogen Inc. and $834,387 at Pfizer Inc.
  • On price to earnings, Biogen Inc. trades at 108.0× and Pfizer Inc. at 42.3×: investors pay more for each dollar of Biogen Inc.'s profit.
  • Biogen Inc.'s revenue grew faster in its latest fiscal year: +2.2% against -1.6% for Pfizer Inc.
  • On the Piotroski F-score, a nine-point test of improving finances, Biogen Inc. scores 4 and Pfizer Inc. 5.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

036731091452020202120222023202420252026Biogen Inc. 51Pfizer Inc. 79

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$25B$51B$76B$101B201720182019202020212022202320242025Biogen Inc. $10BPfizer Inc. $63B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureBiogen Inc.
BIIB · #692 in the world
Pfizer Inc.
PFE · #127 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryPharmaceuticalPharmaceutical
Founded19781849
Size
Market cap$37.5 B$170.7 B
Revenue$9.9 B$62.6 B
Net income$1.3 B$7.8 B▲ best
Employees7,50075,000
Valuation
P/E ratio108×42.3×
Price to sales3.6×2.7×
Price to book2.1×2.0×
Free cash flow yield5.5%▲ best5.3%
Profitability
Gross margin75.7%▲ best74.3%
Net margin13.1%▲ best12.4%
Return on equity7.4%8.9%▲ best
Growth
Revenue growth2.2%▲ best-1.6%
Revenue growth, 3 years a year-0.9%▲ best-14.8%
Earnings per share growth-21.4%-3.5%▲ best
Financial strength
Debt to equity0.3×▲ best0.7×
Cash
Free cash flow margin20.7%▲ best14.5%
Strength scores
Piotroski F-score4 of 95 of 9▲ best
Altman Z-score zone——
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Oct 2026; ratios FY2025

Questions and answers#

Which is bigger, Biogen Inc. or Pfizer Inc.?

Pfizer Inc. is the larger company by market value: $170.7 B against $37.5 B for Biogen Inc., 4.5 times as much (market caps of Oct 23, 2026 for Biogen Inc. and Oct 30, 2026 for Pfizer Inc.).

Which makes more money, Biogen Inc. or Pfizer Inc.?

Pfizer Inc. had more revenue: $62.6 B against $9.9 B for Biogen Inc., both in the year to December 2025. Pfizer Inc. earned more: net income of $7.8 B against $1.3 B for Biogen Inc.

Which is more profitable, Biogen Inc. or Pfizer Inc.?

Biogen Inc. keeps more of each dollar of sales: a net margin of 13.1% against 12.4% for Pfizer Inc.

Which has more employees, Biogen Inc. or Pfizer Inc.?

Pfizer Inc. employs more people: 75,000 against 7,500 at Biogen Inc. Each employee brings in about $1,318,747 of revenue at Biogen Inc. and $834,387 at Pfizer Inc.

Is Biogen Inc. cheaper than Pfizer Inc.?

On price to earnings, Biogen Inc. trades at 108.0× and Pfizer Inc. at 42.3×: investors pay more for each dollar of Biogen Inc.'s profit. A lower multiple is not by itself a better buy: it also reflects expected growth, risk and accounting.

Which is growing faster, Biogen Inc. or Pfizer Inc.?

Biogen Inc.'s revenue grew faster in its latest fiscal year: +2.2% against -1.6% for Pfizer Inc.

Which is financially stronger, Biogen Inc. or Pfizer Inc.?

On the Piotroski F-score, a nine-point test of improving finances, Biogen Inc. scores 4 and Pfizer Inc. 5.